The 1199G > A SNP may help predict the outcomes of paclitaxel chemotherapy in cancer patients, and the ABCB1 (1199A) allele correlates with greater resistance to anti-prostate cancer therapy than the ABCB1 (1199G) allele [7]. This evidence concerns the gene ABCB1 and prostate carcinoma.